...
机译:针对疟原虫肝阶段的药物筛选确定了有效的多阶段抗疟药物
1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal 2Cenix BioScience GmbH, Dresden, Germany 3Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 4Tres Cantos Medicine Development Campus, Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain 5Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zürich, Switzerland 6iMed.UL, Faculdade de Farmácia, Universidade de Lisboa, Portugal;
机译:针对疟原虫肝阶段的药物筛选确定了有效的多阶段抗疟药
机译:Diaminonaphthoquinones,在抗疟疾化合物筛选中鉴定出的主要抗疟疾化学型的恶性疟原虫的杀虫活性强
机译:结构建模鉴定疟原虫4-二膦酸二苯基-2C-甲基-D-赤藓糖醇激酶(ISPE)作为合理的新抗疟药靶标
机译:Prevotella Intermedia 17的硅胶筛选将脂多糖生物合成途径基因鉴定为潜在的药物靶标
机译:探究疟疾寄生虫恶性疟原虫的翻译调控:应用新型体外测定方法来鉴定调控的遗传决定因素并鉴定利用恶性疟原虫翻译作为药物靶点的小分子
机译:针对疟原虫肝阶段的药物筛选确定了有效的多阶段抗疟药物
机译:针对疟原虫肝阶段的药物筛选确定了有效的多阶段抗疟药物